| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 51 |
| 1 | SILDENAFIL CITRATE | 39 |
| 2 | FUROSEMIDE | 37 |
| 3 | MACITENTAN | 30 |
| 4 | SILDENAFIL | 26 |
| 5 | AMBRISENTAN | 24 |
| 6 | SITAGLIPTIN | 24 |
| 7 | SILDENAFIL POWDER, | 21 |
| 8 | ETANERCEPT | 20 |
| 9 | ASPIRIN | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE | 1 | 0.0132 |
| 1 | MIGLUSTAT | 3 | 0.0026 |
| 2 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 3 | CUPRIC OXIDE | 1 | 0.0023 |
| 4 | METRELEPTIN | 2 | 0.0016 |
| 5 | GLYCEROL PHENYLBUTYRATE | 2 | 0.0014 |
| 6 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 7 | EPOPROSTENOL | 15 | 0.0011 |
| 8 | CLINDAMYCIN PHOSPHATE TOPICAL | 4 | 0.0011 |
| 9 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 51 |
| 1 | Loop Diuretic [EPC] | 39 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 35 |
| 3 | Corticosteroid [EPC] | 33 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 33 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 6 | Prostacycline Vasodilator [EPC] | 25 |
| 7 | Benzodiazepine [EPC] | 20 |
| 8 | Osmotic Laxative [EPC] | 18 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Enzyme Stabilizer [EPC] | 3 | 0.0026 |
| 1 | Leptin Analog [EPC] | 2 | 0.0016 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 3 | 0.0011 |
| 3 | Methylating Agent [EPC] | 1 | 0.0010 |
| 4 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 16 | 0.0006 |
| 6 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 7 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 12 | 0.0004 |
| 9 | Endothelin Receptor Antagonist [EPC] | 51 | 0.0003 |